Concurrent Pembrolizumab with AVD for Untreated Classical Hodgkin Lymphoma

Ryan C. Lynch,Chaitra S. Ujjani,Christina Poh,Edus H. Warren,Stephen D. Smith,Mazyar Shadman,Andrei R Shustov,Brian G. Till,Yolanda D. Tseng,Hilary Coye,Megan Shelby,Susan Ottemiller,Hongyan Du,Jacquelin Vandermeer,Heather A. Rasmussen,Stefan Alig,Ash A. Alizadeh,Avanti Gulhane,Delphine Chen, Eric Wayne Dean

Blood（2021）

引用 10|浏览7

暂无评分

摘要

•Concurrent APVD was safe and effective in untreated HL without clinically significant treatment delays.•CR rates by PET were lower than expected at all time points despite only one relapse, and no patient who cleared ctDNA has relapsed to date.

查看译文

关键词

concurrent pembrolizumab,lymphoma,avd

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要